Small Cell Lung Cancer
Small Cell Lung Cancer (SCLC) is a fast-growing type of lung cancer that typically starts in the bronchi and is often associated with smoking. It can spread quickly to other parts of the body, including the brain.
Small Cell Lung Cancer: AL8326 Treatment Study
We are evaluating the safety and effectiveness of the drug AL8326 for patients with small cell lung cancer who have already received prior treatment. This study aims to find the best dose and understand how well the drug works.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years of age or older?
- Do you have a confirmed diagnosis of small cell lung cancer (SCLC)?
- Have you had any major surgery in the past 28 days?
- Do you have any serious heart problems, like uncontrolled high blood pressure or a heart attack in the last 6 months?
- Have you had any active bleeding or serious bleeding problems recently?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Al8326
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Fondazione IRCCS Istituto Nazionale Dei Tumori
Struttura Complessa di Medicina Oncologica I
Milan, Italy
European Institute Of Oncology S.r.l.
Divisione di Sviluppo di Nuovi Farmaci per Terapie Innovative
Opera, Italy
Istituto Oncologico Veneto
Oncologia Medica 2
Padova, Italy
Sponsor: Advenchen Pharmaceuticals LLC
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.